Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So sad to see we are trading at 1,2$ again. Hope we can hold it and create a nice support here. If not we might even see 1$ again. Just crazy for a stock that should be trading between 3-5$...
Dynasil Corp Schedules Fiscal 2017 Second Quarter Financial Results Conference Call:
http://www.prnewswire.com/news-releases/dynasil-corporation-schedules-fiscal-2017-second-quarter-financial-results-conference-call-300452311.html
Right. But after every buy and lack of more bid support someone always brings ask back down for 100 shares. Wondering why... they least news can send DYSL over 2 $ now. Looking forward to the cc.
DYSL some volume. Incredible how thin this is. There aren't many shares available.
After much cost averaging, on the right side of the trade and holding because I think the contracts research and optics are growing and I still don't think much value is assigned to biomedical in the stock price. Any positive XCede trial news and this breaks out to new 52-wk highs. We have 2 reputable investors/partners in Mayo Clinic and Cook who know a whole lot more about XCede than we do and they apparently like the numbers. Last contact w/co., was told the Xcede trial is "on schedule" for dosing patients this year. 3 of 9 required toxicology studies are underway along with QC details and other necessary steps by Cook Biotech. They are happy with their progress. So am I, after Xcede sitting on the shelf so long; it's progress. IMO the lack of progress til now is why the market up to this point has seen XCede as dead money. Any clinical progress with it will increase investor interest and add value to that subsidiary.
Some complain they are not shareholder-friendly, but my emails always were answered.
Man i'm getting SOOOO frustrated in this stock. This is the stock in my port i'm holding the longest. Not yet made one penny on it. Whhhhhaaaaa!!!
Lack of investor awareness, past performance including the drag of XCede, may be contributing factors. Also some have stated that management doesn't seem to be able to sell the story to Wall Street.
On that note, I think investor sentiment is turning around some. We got a partner for XCede to start the pre-clinicals, so positive progress will add value to biomedical and imo share price. Optics is growing. and current administration looks to be interested in increasing defense spending, which is good for RMD. Also, one of Sulick's CC responses seemed to allude that the major holders may be open to selling parts of the company since they own almost half of DYSL and are getting old. He said the board would meet in May, so who knows we may see a buyout or partial asset sale down the road.
It's crazy DYSL is still trading at 1,4$ with all the good news and all the proces going on. This will not stay at these pps much longer. Should trade at least between 3$ - 5$ for now.
$750k NASA Contract, 4/12:
https://www.usaspending.gov/transparency/Pages/TransactionDetails.aspx?RecordID=0E013B25-DCDC-494F-A0EE-46E4497EC457&AwardID=56763681&AwardType=C
$500k DHS Contract, 3/31:
https://www.usaspending.gov/transparency/Pages/TransactionDetails.aspx?RecordID=421459A4-2420-4514-B353-EBB59CAA206A&AwardID=51639214&AwardType=C
Definitely looking up here. Positive Xcede clinical trial news will add a lot of value to the company and boost the share price imo
2 new contract on the USA.gov site https://www.usaspending.gov/Pages/AdvancedSearch.aspx?k=Dynasil pr coming soon?
Some late buying. Nice run but company still undervalued. We should at least be trading between $1.50-2.
Great news today but not yet moving up on the news. Last 2 weeks we are up 15% i hope the trend north is set.
THE E-SHOP IS OPEN. https://www.dynasil.com/ SHOP NOW
hope to see PR today.
Great stuff... pr tomorrow. Nice start of the week. Tnx. D
E-commerce site is up. Last time I emailed company they said 5000 SKUs would be integrated into the website. Probably see a PR next week about it.
https://www.dynasil.com/catalog/
$DYSL
Nice week DYSL. Up 5% on decent volume. Chart indicators setting up a buy.
Crystals grown in space. Pretty cool stuff. Can see the obvious application for DHS and other government. Maybe this is the turnaround we need to begin trading a bit closer towards our valuation
News out and share price moving. $1.45 HOD. Might bring the low float mania crowd if it technically breaks $1.50.
Dynasil Presentation from Annual Meeting 2/23/17
http://www.dynasil.com/assets/DYSL-2017-Annual-Meeting-Reports.pdf
Good explanation of products, current progress for new investors and old
RMD working on Perovskite Solar Cell technology. Take a look. This new technology will be HUGE.
https://www.bloomberg.com/news/articles/2017-03-21/the-wonder-material-that-may-make-spray-on-solar-cells-a-reality
This traded much higher before optics growth, the Cook partnership, or any X-Cede progress whatsoever. It's trading near book. It will take a major event to take this higher, like a buyout or clinical trial news.
This company is not good at keeping communication with shareholders. We want updates, shareholder letters, new platforms, new customers.
Cool stuff indeed. We should likely see RMD grant news again this quarter or next. Glad to see someone else post here with some related content.
Watch this interesting video, it goes into RMD crystal scintillators
Indeed, news would be very welcome. Where is the ecommerce site. Should be pr'd end of Feb.
Seems to be grinding higher. Not too many sellers in the teens. Chart showing signs of reversal, but volume is unconvincing. Grant news or new developments would be nice.
Com on Mr Sulick! Where is the ecommerce site??? Waiting for almost 3 years now... all stocks are making new hights and DYSL not moving a dime... DYSL might be worth 4 Dollar as you say, but we are still trading at 1,2$... please give us at least something.
Where is the webstore news? Should be out in feb 2017... Last day is today...??? Com on mr Sulick.
Same here... E-commerce should be up and running in Feb 2017 so that or we can expect soon. But much more happening imo. We'll soon find out.
Well I 100% agree on that. Imo I think some traders sold on that news, still imo i think they are wrong. I don't see why the insiders would dilute all the shares they are holding. Havd
declaes I agree, they can raise without dilution.
I was just point out to something that could have triggered the heavy sell orders. so just trying to give na explanation to the big down day when result were released.
Now let's hope something exciting gets out from the meeting.
Fabius, the company is different because they already have employees and is already operating, but as I understand, they are in the same business as Xcede.
"We don't have the money to do it, we would have to raise the money" But that doesn't necessarily mean they will do it via diluting. Hope to hear something more about this deal on the annual meeting today.
We will have a special section for Xcede there...should be very interesting
from my understanding it is not for Xcede, but it is another potential acquisition: see below
from the last CC
"The other thing I mentioned in my prepared remarks is that we are looking at a potential acquisition that could assist with Xcede. It had -- they have a number of employees already, it's an operating company as oppose to a development stage company, and so it's significantly different than Xcede is at the moment.
But it could really jump-start that business, if we can pull it off. We don't have the money to do it, we would have to raise the money. We're not real clear on what that structure would look like yet, there's a lot of imponderables about this thing at the moment. But the first step is, if we have done some due diligence we visited the company a few times, we believe that it's an acquisition that is worth doing, if we -- if it's accepted. And -- but there's a lot of time, distance and work that has to be done before we get to that plan. And even if we are now -- if our LOI is accepted it's not likely that we would close this transaction for about six months, would be our guess. But it does give us yet another option in the value proposition of Xcede so."
Fabius, why do you think DYSL will raise money via diluting to finance Xcede. There are some other potential paths, that would be much better for shareholders. Don't forget insiders are holding a lot of shares here. I think DYSL will surge for better options and do have other solutions in mind. Try to read between the lines on the CC.
Ok sneller is go e on the ask it seems... Iets move up again. This is getting ridicelous...
I agree, but we are talking about speculators and not investors.
As i said before offering shares to buy a company is not dilluting. You get something for those shares that has a value and generate income. The value of the company goes up. If investors don't understand that, it's better they stop investing. It's not like you dillute to pay the bills or pay your people.
They push the price down, waiting for possible dilution; then, when the price looks particularly cheap (new shares issue or not) then they jump in.
tiny caps are played until the company is able to dissolve uncertainty (whatever it is)
Fingers crossed for the weeks to come
I think you are right. But if you have something agains investing money in a company to make huge profits..??? I don't understand what those people are doing in the stockmarket...
I believe the statement I outlined about the CC, where they say they have no money for the potential M&A is the reason we may have even lower prices.
I do agree there is some huge potential development, but as far as the masrket sees the potential for dilution...
Anyway if it goes down I am ready to buy more.
GLTY
CRAZY. everybody who is selling here is just stupid and has done NO DD.
Followers
|
11
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
704
|
Created
|
08/22/06
|
Type
|
Free
|
Moderators |
Innovating Science, Research & Technology
Dynasil specializes in the development and manufacture of detection, sensing and analysis technology, precision instruments and optical components. Our products target high-growth applications in the homeland security, medical and industrial markets.
Technology leadership and innovation drives our economy and fuels America’s competitiveness in the global market. It is what pushes us to strive and grow. The same is true of our organization. One of the hallmarks of Dynasil is its strong business model built on innovating science, research and technology, and its successful track record of bringing technology to market.
COMPANY CONTACT INFORMATION:
44 Hunt Street
Watertown, MA 02472
Phone: 617-668-6855
Fax: 617-668-6890
Map
Peter Sulick, Interim President and CEO
Tom Leonard, CFO
Patty Kehe, Corporate Secretary
44 Hunt Street
Watertown, MA 02472
Phone: 617-668-6800
Fax: 617-926-9980
Map
Request Information via Email
8 Nemco Way
Stony Brook Industrial Park
Ayer, MA 01432
Phone: 978-772-1700
Fax: 978-772-0017
Map
Website
Request Information via Email
Unit R1 Westwood Estate
Margate, Kent, CT9 4JL, England
Phone: 01843 231166
International +44 1843 231166
Fax: +44 1843 290310
Map
Website
Request Information via Email
239 Cherry Street
Ithaca, NY 14850
Phone: 607-272-3220
Fax: 607-272-3369
Map
Website
Request Information via Email
385 Cooper Road
West Berlin, NJ 08091
Phone: 856-767-4600
Fax: 856-767-6813
Map
Website
Request Information via Email
WEBSITE: http://dynasil.com
TRADING EXCHANGE LISTING: NASDAQ Dynasil Corporation of America (NASDAQ: DYSL)
YEAR OF INCORPORATION: 1960
Through a series of acquisitions, Dynasil has evolved from a single-product line optics company providing synthetic fused silica to an emerging-growth company focused on commercializing its own products, patenting its own innovations and advancing its own technologies. Our revenue has increased from $2 million in FY 2004 to nearly $43 million in FY 2013.
Peter Sulick Chairman of the Board, Interim Chief Executive Officer and President |
Thomas C. Leonard Chief Financial Officer |
Patricia Kehe Corporate Secretary |
NUMBER Of ELOYEES 222 (as of 01/01/2014)
SEC REPORTING STATUS: Fully Reporting
FISCAL YEAR END: 09/30
SHARE STRUCTURE:
Authorized Shares: 25,000,000 (as of 01/01/2014)
Shares Outstanding: 15,020,000 (as of 01/01/2014)
Float: 8,310,000 Shares (as of 01/01/2014)
ONE YEAR STOCK PRICE & VOLUME CHART:
DISCLAIMER: Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information contained herein.
http://seekingalpha.com/article/1901271-dynasil-corporation-of-america-a-risky-1-stock-with-significant-upside-potential
http://seekingalpha.com/article/2116603-dynasil-turnaround-not-priced-into-the-stock?source=yahoo
http://ih.advfn.com/p.php?pid=nmona&article=62166372 (Q2 results)
http://biz.yahoo.com/e/140924/dysl8-k.html (Change in Directors or Principal Officers)
http://finance.yahoo.com/news/dynasil-announces-completion-xcede-technologies-142000369.html (Dynasil Announces Completion of Xcede Technologies' $2 Million Convertible Note Financing)
Volume |